NDC 69238-1345-01 - Albuterol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69238-1345
- Requested NDC
- 69238-1345-01
- Package NDCs from labels
- 69238-1345-1, 69238-1345-5, 69238-1345-01
- Manufacturer
- Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited
- Effective date
- 2026-04-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albuterol Tablets, USP (2 mg and 4 mg) Rx only | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 2026-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-1345-1 | Albuterol | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 69238-1345-5 | Albuterol | 500 in 1 BOTTLE | TABLET | 500 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69238-1345 | ALBUTEROL TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20241220_230d66fc-f62c-42a6-adb3-0a0f879c8ad4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69238-1345-1 | EA - Each | 69238-1345 | e73f277e-4294-4cb5-8048-55da25e57b2f | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Exelan Pharmaceuticals, Inc. | 29e35e54-dbd6-4426-993f-893d7a4d69be | 2022-02-10 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 8153d82c-b5c5-4aa2-bce5-b69cf2d23f5d | 2020-10-16 | Warnings, Adverse reactions | 021SEF3731 |
| ProAir RespiClick | ALBUTEROL SULFATE | Teva Respiratory, LLC | 9324e2eb-26fd-4f14-9f10-e5aa467306f4 | 2020-09-30 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | Teva Pharmaceuticals USA, Inc. | 7bb5b6dd-9105-4ee7-b205-ed79cf4b371b | 2020-05-31 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Mylan Pharmaceuticals Inc. | 23c05e9a-9df5-4978-8831-cf562aa4ba92 | 2018-12-12 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.